Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer
Naoko Matsuda,Xiaoping Wang,Bora Lim,Savitri Krishnamurthy,Ricardo H. Alvarez,Jie S. Willey,Charla A. Parker,Juhee Song,Yu Shen,Jianhua Hu,Wenhui Wu,Nan Li,Gildy V. Babiera,James L. Murray,Banu K. Arun,Abenaa M. Brewster,James M. Reuben,Michael C. Stauder,Chad M. Barnett,Wendy A. Woodward,H. T. Carisa Le-Petross,Anthony Lucci,Sarah M. DeSnyder,Debu Tripathy,Vicente Valero,Naoto T. Ueno
JAMA Oncology.2018;4(9)1207
[DOI]
2Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: what is the role for surgery?
Musaddiq Awan,Neelesh Sharma,Christopher W. Towe,Jimmy T. Efird,Mitchell Machtay,Tithi Biswas
Expert Review of Anticancer Therapy.2016;16(11)1131
[DOI]
3Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness
Qianjun Zhou,Qing Geng,Lin Wang,Jia Huang,Meilin Liao,Yan Li,Zhengping Ding,Shentu Yang,Hang Zhao,Qiang Shen,Changqing Pan,Jiatao Lou,Shun Lu,Chang Chen,Qingquan Luo
EBioMedicine.2019;41(11)236
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal